Allopregnanolone serum concentrations and neurosteroid sensitivity during withdrawal from postmenopausal hormone therapy

References

• Lethaby A, Suckling J, Barlow D, Farquhar C M, Jepson R G, Roberts H. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. Cochrane Database Syst Rev 2004, 3 Art. No., D000402
   PubMedGoogle Scholar
• Hammarback S, Backstrom T, Holst J, von Schoultz B, Lyrenas S. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen–progestagen postmenopausal replacement therapy. Acta Obstet Gynecol Scand 1985; 64: 393–397
   PubMed Web of Science ®Google Scholar
• Bjorn I, Bixo M, Nojd K S, Collberg P, Nyberg S, Sundström-Poromaa I, Bäckström T. The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy. Gynecol Endocrinol 2002; 16: 1–8
   PubMed Web of Science ®Google Scholar
• Bjorn I, Bixo M, Nojd K S, Nyberg S, Backstrom T. Negative mood changes during hormone replacement therapy: a comparison between two progestogens. Am J Obstet Gynecol 2000; 183: 1419–1426
   PubMed Web of Science ®Google Scholar
• Wihlback A C, Sundstrom-Poromaa I, Nyberg S, Backstrom T. Sensitivity to a neurosteroid is increased during addition of progestagen to postmenopausal hormone replacement therapy. Neuroendocrinology 2001; 73: 397–407
   PubMed Web of Science ®Google Scholar
• Andreen L, Bixo M, Nyberg S, Sundstrom-Poromaa I, Backstrom T. Progesterone effects during sequential hormone replacement therapy. Eur J Endocrinol 2003; 148: 571–577
   PubMed Web of Science ®Google Scholar
• Backstrom T, Andreen L, Birzniece V, Björn I, Johansson I M, Nordenstam-Haghjo M, Nyberg S, Sundström-Poromaa I, Wahlström G, Wang M, et al. The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs 2003; 17: 325–342
   PubMed Web of Science ®Google Scholar
• Baulieu E E. Neurosteroids: a new function in the brain. Biol Cell 1991; 71: 3–10
   PubMed Web of Science ®Google Scholar
• Majewska M D, Harrison N L, Schwartz R D, Barker J L, Paul S M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986; 232: 1004–1007
   PubMed Web of Science ®Google Scholar
• Andreen L, Sundstrom-Poromaa I, Bixo M, Andersson A, Nyberg S, Backstrom T. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. Psychoneuroendocrinology 2005; 30: 212–224
   PubMed Web of Science ®Google Scholar
• Wihlback A C, Nyberg S, Backstrom T, Bixo M, Sundstrom-Poromaa I. Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women. Psychoneuroendocrinology 2005; 30: 38–50
   PubMed Web of Science ®Google Scholar
• Andreen L, Sundstrom-Poromaa I, Bixo M, Nyberg S, Backstrom T. Allopregnanolone concentration and mood – a bimodal association in postmenopausal women treated with oral progesterone. Psychopharmacology (Berl) 2006; 187: 209–221
   PubMed Web of Science ®Google Scholar
• Hommer D W, Matsuo V, Wolkowitz O, Chrousos G, Greenblatt D J, Weingartner H, Paul S M. Benzodiazepine sensitivity in normal human subjects. Arch Gen Psychiatry 1986; 43: 542–551
   PubMed Web of Science ®Google Scholar
• Ball D M, Glue P, Wilson S, Nutt D J. Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil. Psychopharmacology (Berl) 1991; 105: 361–367
   PubMed Web of Science ®Google Scholar
• Sundstrom I, Andersson A, Nyberg S, Ashbrook D, Purdy R H, Backstrom T. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 1998; 67: 126–138
   PubMed Web of Science ®Google Scholar
• Timby E, Balgard M, Nyberg S, Spigset O, Andersson A, Porankiewicz-Asplund J, Purdy R H, Zhu D, Bäckström T, Poromaa I S. Pharmacokinetic and behavioral effects of allopregnanolone in healthy women. Psychopharmacology (Berl) 2006; 183: 414–424
   Google Scholar
• Sundstrom I, Backstrom T. Patients with premenstrual syndrome have decreased saccadic eye velocity compared to control subjects. Biol Psychiatry 1998; 44: 755–764
   PubMed Web of Science ®Google Scholar
• Gallo M A, Smith S S. Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: a possible rat model of PMS anxiety. Pharmacol Biochem Behav 1993; 46: 897–904
   PubMed Web of Science ®Google Scholar
• Moran M H, Smith S S. Progesterone withdrawal I: pro-convulsant effects. Brain Res 1998; 807: 84–90
   PubMed Web of Science ®Google Scholar
• Smith S S, Gong Q H, Hsu F C, Markowitz R S, ffrench-Mullen J M, Li X. GABA(A) receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 1998; 392: 926–930
   PubMed Web of Science ®Google Scholar
• Smith S S, Gong Q H, Li X, Moran M H, Bitran D, Frye C A, Hsu F C. Withdrawal from 3α-OH-5α-pregnan-20-one using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor α4 subunit in association with increased anxiety. J Neurosci 1998; 18: 5275–5284
   PubMed Web of Science ®Google Scholar
• Marshall R W, Griffiths A N, Richens A. A microcomputer system to assess CNS depression from the ananlysis of the dynamics of saccadic eye movements. Br J Clin Pharmacol 1985; 20(Suppl 1)304–305
   Google Scholar
• Marshall R W, Richens A. An IBM-based system for the generation, collection and analysis of saccadic and smooth pursuit eye movements. Br J Clin Pharmacol 1989; 28: 752–753
   Web of Science ®Google Scholar
• Baloh R W, Sills A W, Kumley W E, Honrubia V. Quantitative measurement of saccade amplitude, duration, and velocity. Neurology 1975; 25: 1065–1070
   PubMed Web of Science ®Google Scholar
• Frye C A, Rhodes M E. Estrogen-priming can enhance progesterone's anti-seizure effects in part by increasing hippocampal levels of allopregnanolone. Pharmacol Biochem Behav 2005; 81: 907–916
   PubMed Web of Science ®Google Scholar
• Landgren S, Selstam G. Interaction between 17β-oestradiol and 3α-hydroxy-5α-pregnane-20-one in the control of neuronal excitability in slices from the CA1 hippocampus in vitro of guinea-pigs and rats. Acta Physiol Scand 1995; 154: 165–176
   PubMedGoogle Scholar